In addition, TNF signaling has been shown to act as a tumor accomplice in HNSCC by decreasing tumor cell apoptosis or promoting an immune-suppressive tumor microenvironment (Sandra et al., 2002; Lu et al., 2011). The gene discussed is TNF; the disease is head and neck squamous cell carcinoma.